Trwa ładowanie...
Notowania

SPH sales revenues for April 2022

“Sopharma” AD (the Company) notifies that for April 2022 the Company recorded an increase in sales of 44% compared to the same month of the previous year, incl. 60% increase in domestic sales and 38% increase in export sales as a result of erratic recovery of activity in major foreign markets.
For the four months since the beginning of the year the revenues from sales of products increase by 34%, incl. 75% increase of sales for the domestic market and 10% increase in export sales.

Załączniki

Inne komunikaty